Playboy Gets Fired Up For Cannabis Advocacy and Reform
by Kat Helgeson
According to written testimony from a current Justice Department official, Attorney General William Barr improperly diverted Justice Department resources to scrutinize cannabis company mergers because he doesn’t like the cannabis industry.
John Elias, a veteran employee at ATR, testified to the House Judiciary Committee that the merger investigations by the agency into cannabis companies didn’t “even come close to meeting established criteria” for such an inquiry. Elias claims that the investigations were only opened due to Barr’s personal distaste for legalized cannabis.
The written testimony reads:
“Across all sectors of the American economy, the cannabis industry accounted for a full 29 percent of the Division’s Second Request investigations in Fiscal Year 2019… At one point, cannabis investigations accounted for five of the eight active merger investigations in the office that is responsible for the transportation, energy, and agriculture sectors of the American economy. The investigations were so numerous that staff from other offices were pulled in to assist, including from the telecommunications, technology, and media offices.”
In a June 11 memo, the U.S. Department of Justice Office of Professional Responsibility Director and Chief Counsel Jeffrey Ragsdale defended the agency’s cannabis investigations by the Antitrust Division (ATR), saying the cannabis industry “provided a unique challenge to federal and state regulators alike.”
Mergers are usually only subjected to antitrust investigations if they are likely to have an impact on competition or create a monopoly. A federal prosecutor told House lawmakers that Attorney General William Barr ordered antitrust staffers to investigate 10 proposed mergers in the cannabis sector because of his personal dislike of the industry.
“While these were nominally antitrust investigations, and used antitrust investigative authorities, they were not bona fide antitrust investigations,” said Elias. “Nonetheless, they accounted for 29% of the Antitrust Division’s full-review merger investigations in Fiscal Year 2019.”
After staffers expressed concerns, division head Makam Delrahim acknowledged at an all-staff meeting that “the investigations were motivated by the fact that the cannabis industry is unpopular ‘on the fifth floor,’ a reference to Attorney General Barr’s offices in the D.O.J. headquarters building.”
Traditionally, antitrust investigations are supposed to be about making sure a company can’t jack up prices in the market by buying a competitor. But Barr is hardly concerned about ensuring medical cannabis smokers don’t pay too much for their buds. Instead, he’s poured enormous resources into antitrust probes of cannabis companies out of personal bias against their underlying business, Elias claims.
The only legal restraint on Barr is found in the Rohrabacher Farr Amendment (also known as the Rohrabacher–Blumenauer amendment). This legislation prevents the DOJ from spending funds to interfere with the implementation of state medical cannabis laws (emphasis intended). In the weeks since, dozens of House members have introduced a resolution calling for a possible impeachment inquiry into Barr as he “abused the power of his office” to improperly investigate cannabis businesses and allegedly engaged in other unlawful conduct. The operative word here is “improperly.”
All over the world, nations have taken to raising breast cancer awareness throughout the month of October. This annual campaigning is done in hopes of empowering women and their loved ones with knowledge and information concerning one of the most common cancers out there affecting women. If the year 2020 has taught us anything, it’s…
COVID-19, SARS-CoV-2, Coronavirus… whichever name you choose to refer to the pandemic, has recently held many countries captive to its contagiousness. The virus first appeared in China in December 2019 and has impacted the lives of countless people, whether due to the virus itself or due to the restrictions imposed by governments as a result….
People suffering from Inflammatory Bowel Disease (IBD) or Irritable Bowel Syndrome (IBS) can go through excruciating pain, numbness or struggle with a minefield of digestion. Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Both IBD and IBS have a major impact on the…
Cannabis legalization is happening regardless of the US federal government’s draconian stance on the subject. State lawmakers are starting to listen to the people’s will over the misguided statements of the feds. Despite cannabis remaining against the law on a federal level, many states have been allowing the sale, cultivation, and consumption of cannabis, with…
The burgeoning cannabis market is one of the most highly regulated and taxed sectors in the United States. The industry is saturated with regulations and restrictions, many of which lead to significant security risks such as having large sums of cash on site of dispensaries due to the lack of banking access within the industry….
Note: Veriheal does not intend to give this as professional medical advice. Do not attempt to self-diagnose, or prescribe treatment based on…